Suppr超能文献

[维拉帕米在白血病原始细胞耐药性检测中的应用]

[The use of verapamil in tests for determining the drug resistance of leukemic blasts].

作者信息

Mukhammed A, Turkina A G, Al'pidovskiĭ V K, Sidorova T A, Golenko O D, Gerasimova G K

出版信息

Gematol Transfuziol. 1993 May;38(5):10-4.

PMID:8034162
Abstract

To determine prognostically unfavourable groups of acute leukemia patients, the authors studied the in vitro accumulation of 3H-vincristine (Vcr) and adriamycin (ADR) as well as inclusion of 3H-cytosar (Ara-C) into marrow blast DNA from patients showing different effects of treatment. It was found resistant to induction chemotherapy increases with verapamil addition to culture medium (Vrp+ cells). ADR inclusion into Vrp+ cells was the same as that into Vrp- cells. The inclusion of 3H-Ara-C into S-phase cell DNA in the cells Vrp+ was 3 time that in the cells Vrp-. All the responders to cytosar treatment had Vrp- blasts. It is evident that evaluation of Vrp effect on 3H-Vcr accumulation under short-term culturing is able to indicate groups of patients with low probability of achieving complete remissions in response to standard regimens of Vcr, Ara-C and anthracyclines treatment.

摘要

为了确定急性白血病患者预后不良的群体,作者研究了体外3H-长春新碱(Vcr)和阿霉素(ADR)的蓄积情况,以及来自显示不同治疗效果患者的骨髓原始细胞DNA中3H-阿糖胞苷(Ara-C)的掺入情况。研究发现,随着培养基中加入维拉帕米(Vrp+细胞),对诱导化疗的耐药性增加。ADR掺入Vrp+细胞的情况与掺入Vrp-细胞的情况相同。Vrp+细胞中3H-Ara-C掺入S期细胞DNA的量是Vrp-细胞中的3倍。所有对阿糖胞苷治疗有反应的患者都有Vrp-原始细胞。显然,在短期培养下评估Vrp对3H-Vcr蓄积的影响能够表明那些对Vcr、Ara-C和蒽环类药物标准治疗方案实现完全缓解可能性低的患者群体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验